Trials / Recruiting
RecruitingNCT05553093
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
Nanjing First Hospital, Nanjing Medical University
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The effects of Tirzepatide and Insulin Glargine on glucose and lipid metabolism and inflammation in patients with type 2 diabetes mellitus. Effects of Tirzepatide on the occurrence and development of cognitive impairment in diabetic patients and its associated pattern of changes in brain neural network characteristics.
Detailed description
The aim of the study is to investigate the effects of Tirzepatide and Insulin Glargine on glucose and lipid metabolism and inflammation in patients with type 2 diabetes mellitus. Meanwhile, this study will evaluate the effects of Tirzepatide on the development of cognitive impairment and its associated pattern of changes in neural network characteristics in diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tirzepatide | Tirzepatide ih qw |
| DRUG | Insulin Glargine | 6 IU ih qd |
Timeline
- Start date
- 2022-03-15
- Primary completion
- 2023-12-31
- Completion
- 2027-10-31
- First posted
- 2022-09-23
- Last updated
- 2022-09-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05553093. Inclusion in this directory is not an endorsement.